bpc 157 cas number BPC-157 10mg – Peptide Producer BPC-157 Peptide | Tissue Repair
Description
Retrieved 21 February 2022
Poor exercise recovery and injury prone
Theres just one small problem: not a single randomized controlled trial has ever been completed in humans
Reported issues include: Injectionsite reactions: Pain, tenderness, redness or swelling at the injection site
Clinically, this manifests as peripheral neuropathy, characterized by numbness, painful tingling, burning sensations in the extremities, and eventual loss of motor function
Hims is part of Hims & Hers, which cheered the FDAs decision to re-evaluate the drugs status
